Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 400

    1.

    A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial.

    Beyth RJ, Quinn L, Landefeld CS.

    Ann Intern Med. 2000 Nov 7;133(9):687-95.PMID: 11074901 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting.

    Willey VJ, Bullano MF, Hauch O, Reynolds M, Wygant G, Hoffman L, Mayzell G, Spyropoulos AC.

    Clin Ther. 2004 Jul;26(7):1149-59.PMID: 15336480 [PubMed - indexed for MEDLINE]Related articles

    3.

    Guideline-based consultation to prevent anticoagulant-related bleeding. A randomized, controlled trial in a teaching hospital.

    Landefeld CS, Anderson PA.

    Ann Intern Med. 1992 May 15;116(10):829-37.PMID: 1567097 [PubMed - indexed for MEDLINE]Related articles

    4.

    A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

    Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR, Turpie AG, Green D, Ginsberg JS, Wells P, MacKinnon B, Julian JA.

    N Engl J Med. 1999 Mar 25;340(12):901-7. Erratum in: N Engl J Med 1999 Jul 22;341(4):298. PMID: 10089183 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.

    Kearon C, Ginsberg JS, Kovacs MJ, Anderson DR, Wells P, Julian JA, MacKinnon B, Weitz JI, Crowther MA, Dolan S, Turpie AG, Geerts W, Solymoss S, van Nguyen P, Demers C, Kahn SR, Kassis J, Rodger M, Hambleton J, Gent M; Extended Low-Intensity Anticoagulation for Thrombo-Embolism Investigators.

    N Engl J Med. 2003 Aug 14;349(7):631-9.PMID: 12917299 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.

    DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P, Lam L, McGowan C, Lee G, DeCaro M, Ruggiero N, Singhal S, Greenspon A.

    Pharmacotherapy. 2007 May;27(5):691-6.PMID: 17461704 [PubMed - indexed for MEDLINE]Related articles

    7.

    Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.

    [No authors listed]

    Arch Intern Med. 1996 Feb 26;156(4):409-16.PMID: 8607726 [PubMed - indexed for MEDLINE]Related articles

    8.

    Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.

    Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, Bounameaux H, Glynn RJ; PREVENT Investigators.

    N Engl J Med. 2003 Apr 10;348(15):1425-34. Epub 2003 Feb 24.PMID: 12601075 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism. A randomized, double-blind, controlled trial.

    Kovacs MJ, Rodger M, Anderson DR, Morrow B, Kells G, Kovacs J, Boyle E, Wells PS.

    Ann Intern Med. 2003 May 6;138(9):714-9.PMID: 12729425 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial.

    Francis CW, Davidson BL, Berkowitz SD, Lotke PA, Ginsberg JS, Lieberman JR, Webster AK, Whipple JP, Peters GR, Colwell CW Jr.

    Ann Intern Med. 2002 Oct 15;137(8):648-55.PMID: 12379064 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The impact of pharmacist-managed oral anticoagulation therapy in older veterans.

    Poon IO, Lal L, Brown EN, Braun UK.

    J Clin Pharm Ther. 2007 Feb;32(1):21-9.PMID: 17286786 [PubMed - indexed for MEDLINE]Related articles

    12.

    Prevention of venous thromboembolism after knee arthroplasty. A randomized, double-blind trial comparing enoxaparin with warfarin.

    Leclerc JR, Geerts WH, Desjardins L, Laflamme GH, L'Espérance B, Demers C, Kassis J, Cruickshank M, Whitman L, Delorme F.

    Ann Intern Med. 1996 Apr 1;124(7):619-26.PMID: 8607589 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.

    Fiessinger JN, Huisman MV, Davidson BL, Bounameaux H, Francis CW, Eriksson H, Lundström T, Berkowitz SD, Nyström P, Thorsén M, Ginsberg JS; THRIVE Treatment Study Investigators.

    JAMA. 2005 Feb 9;293(6):681-9.PMID: 15701909 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice.

    Abdelhafiz AH, Wheeldon NM.

    Am J Geriatr Pharmacother. 2008 Mar;6(1):1-11.PMID: 18396243 [PubMed - indexed for MEDLINE]Related articles

    15.

    The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation.

    Khan TI, Kamali F, Kesteven P, Avery P, Wynne H.

    Br J Haematol. 2004 Aug;126(4):557-64.PMID: 15287950 [PubMed - indexed for MEDLINE]Related articles

    16.

    Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial.

    Crowther MA, Ageno W, Garcia D, Wang L, Witt DM, Clark NP, Blostein MD, Kahn SR, Vesely SK, Schulman S, Kovacs MJ, Rodger MA, Wells P, Anderson D, Ginsberg J, Selby R, Siragusa S, Silingardi M, Dowd MB, Kearon C.

    Ann Intern Med. 2009 Mar 3;150(5):293-300.PMID: 19258557 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A randomized trial of patient self-managed versus physician-managed oral anticoagulation.

    Sunderji R, Gin K, Shalansky K, Carter C, Chambers K, Davies C, Schwartz L, Fung A.

    Can J Cardiol. 2004 Sep;20(11):1117-23.PMID: 15457308 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial.

    Albers GW, Diener HC, Frison L, Grind M, Nevinson M, Partridge S, Halperin JL, Horrow J, Olsson SB, Petersen P, Vahanian A; SPORTIF Executive Steering Committee for the SPORTIF V Investigators.

    JAMA. 2005 Feb 9;293(6):690-8.PMID: 15701910 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

    Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM, Jensvold NG, Selby JV, Singer DE.

    JAMA. 2003 Nov 26;290(20):2685-92.PMID: 14645310 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism.

    Wells PS, Forgie MA, Simms M, Greene A, Touchie D, Lewis G, Anderson J, Rodger MA.

    Arch Intern Med. 2003 Apr 28;163(8):917-20.PMID: 12719200 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data